Cargando…
Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs
BACKGROUND: Radiogenetic therapy is a novel approach in the treatment of cancer, which employs genetic modification to alter the sensitivity of tumor cells to the effect of applied radiation. AIM: To select a potent radiation inducible promoter in the context of brain tumors and to investigate if CA...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332320/ https://www.ncbi.nlm.nih.gov/pubmed/28251571 http://dx.doi.org/10.1186/s40169-017-0140-y |